Team players and helpers – describing professional identity among finnish physicians in a cross-sectional study

Autor: Pyry Mattila, Harri Hyppölä, Teppo Heikkilä, Sami Heistaro, Minna Kaila, Petri Kulmala, Markku Sumanen, Pekka Mäntyselkä

Publikováno v: BMC Medical Education, Vol 24, Iss 1, Pp 1-12 (2024)

Abstract Background Every physician has a unique professional identity. However, little is known about the diversity of identities among physicians. This study aimed to quantitatively assess the professional identity of physicians in Finland using de

Externí odkaz: https://doaj.org/article/b152623ba8f3401c93d1d12fbbfe931a

Cost-minimization modeling of venous thromboembolism diagnostics: performing limited compression ultrasound in primary health care reduces costs compared to referring patients to a hospital

Autor: Ossi Hannula, Anssi Mustonen, Suvi Rautiainen, Ritva Vanninen, Harri Hyppölä

Publikováno v: The Ultrasound Journal, Vol 13, Iss 1, Pp 1-9 (2021)

Abstract Background The aim of this retrospective study was to determine whether diagnosing a deep venous thrombosis (DVT) in primary health care using limited compression ultrasound (LCUS) can save resources compared to referring these patients to h

Externí odkaz: https://doaj.org/article/798906e4efb44398905bf171d7fd4476

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Autor: Izzet Altintas, Jesper Eugen-Olsen, Santeri Seppälä, Jens Tingleff, Marius Ahm Stauning, Nora Olsen El Caidi, Sanaá Elmajdoubi, Hejdi Gamst-Jensen, Mette B Lindstrøm, Line Jee Hartmann Rasmussen, Klaus Tjelle Kristiansen, Christian Rasmussen, Jan O Nehlin, Thomas Kallemose, Harri Hyppölä, Ove Andersen

Publikováno v: Biomarker Insights, Vol 16 (2021)

Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with

Externí odkaz: https://doaj.org/article/a372f7d0a4a547489c5b936a7c01e65f

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients

Autor: Ria M. Holstein, Santeri Seppälä, Johanna Kaartinen, Mari Hongisto, Harri Hyppölä, Maaret Castrén

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3283

Emergency department (ED) overcrowding is a global issue setting challenges to all care providers. Elderly patients are frequent visitors of the ED and their risk stratification is demanding due to insufficient assessment methods. A prospective cohor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a564384b1157aa4f485a330aa8e04bd7

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Autor: Christian Rasmussen, Ove Andersen, Santeri Seppälä, Thomas Kallemose, Line Jee Hartmann Rasmussen, Jens Tingleff, Jan O. Nehlin, Sanaá Elmajdoubi, Izzet Altintas, Mette Bendtz Lindstrøm, Nora Olsen El Caidi, Harri Hyppölä, Klaus Tjelle Kristiansen, Marius Ahm Stauning, Jesper Eugen-Olsen, Hejdi Gamst-Jensen

Publikováno v: Biomarker Insights
Biomarker Insights, Vol 16 (2021)
Altintas, I, Eugen-Olsen, J, Seppälä, S, Tingleff, J, Stauning, M A, El Caidi, N O, Elmajdoubi, S, Gamst-Jensen, H, Lindstrøm, M B, Rasmussen, L J H, Kristiansen, K T, Rasmussen, C, Nehlin, J O, Kallemose, T, Hyppölä, H & Andersen, O 2021, ' suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19 ', Biomarker Insights, vol. 16, pp. 1-12 . https://doi.org/10.1177/11772719211034685

Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654574ad00defc92b174fb2b255d9d93
http://europepmc.org/articles/PMC8371731